Oral News and Research

RSS

Screening tool could help oral cancer detection

Indian researchers report the development of a novel, simple screening tool with a high degree of accuracy for the detection of oral premalignancies that can be used in a general health setting without the need for much training or clinical experience.

2 Aug 2012

Opinion of artificial hydration varies by ethnicity

Ethnicity influences whether patients at the end of life and their carers view artificial hydration as food or medicine, with more individuals from ethnic minorities viewing it as food than non-Hispanic European Americans, show US study results.

1 Aug 2012

Research supports ability of some herbal agents against sunburn

Recent research supports the ability of some herbal agents, taken orally or applied topically, to prevent sunburn and limit the damage caused by excessive exposure to ultraviolet (UV) light.

1 Aug 2012

Teplizumab type I diabetes prevention study now enrolls younger children

A type I diabetes prevention study that is part of the TrialNet program at Vanderbilt is now enrolling children as young as 8 years old, following an FDA decision allowing the drug Teplizumab (anti-CD3) to be used in younger children.

1 Aug 2012

Array BioPharma announces positive results from ARRY-797 Phase 2 trial on osteoarthritis

Array BioPharma today announced that ARRY-797 met its primary endpoint in a randomized, placebo-controlled and active-controlled (oxycodone ER) Phase 2 clinical trial in 157 osteoarthritis patients suffering from moderate to severe knee pain despite the use of non-steroidal anti-inflammatory drugs (NSAIDs).

31 Jul 2012

Top-line results from Pfizer's tofacitinib Phase 3 study on moderate-to-severe active RA

Pfizer Inc. announced today top-line results from ORAL Start (A3921069), a Phase 3 study of the investigational agent tofacitinib, a novel, oral Janus kinase (JAK) inhibitor for the treatment of adults with moderate-to-severe active rheumatoid arthritis (RA).

31 Jul 2012

Flap design affects recovery from wisdom tooth surgery

The design of the mucoperiosteal flap created during surgical removal of impacted mandibular third molars can affect patient recovery, show study findings.

31 Jul 2012

Treatments for peripheral neuropathic pain compared

The first study to compare the 8% capsaicin patch with pregabalin as a treatment for peripheral neuropathic pain begins, with enrolment of the first patient.

31 Jul 2012

Stem cell therapy holds promise for craniofacial bone repair

In the first human study of its kind, researchers found that using stem cells to re-grow craniofacial tissues-mainly bone-proved quicker, more effective and less invasive than traditional bone regeneration treatments.

31 Jul 2012

Sleep related diabetes risk needs attention

Strategies aimed at improving sleep quality among individuals without Type 2 diabetes may act as an additional tool in diabetes prevention, report researchers.

30 Jul 2012

Encouraging results from Tonix TNX-102 SL clinical trial for fibromyalgia syndrome

Tonix Pharmaceuticals Holding Corp., a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system, including fibromyalgia syndrome and post-traumatic stress disorder, announces that the clinical portion of a human study of a solution version of TNX-102 2.4 mg sublingual tablets has completed.

30 Jul 2012

Patients with plantar fasciitis experience less pain and improved QOL after standard radiation therapy

Patients with plantar fasciitis (painful bone heel spur) experience significantly less pain and improved quality of life following a standard dose of external beam radiation therapy, a common cancer treatment similar to receiving an X-ray, according to a randomized, cooperative group study that was published online July 25, 2012, in the International Journal of Radiation, Oncology, Biology, Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO).

30 Jul 2012

Roundup: Mass. lawmakers struggle to reach agreement on cost controls; $100M grant for Calif. stem cell research; N.C. to move mentally ill from elderly homes

The House and Senate are under the gun to reach an agreement on how to lower health care costs while improving care. A conference committee aims to have a bill out on Sunday. Their deadline is Monday evening. In the meantime, several major issues are still unresolved, including what to do about hospitals that use their market clout to demand high prices that are not based on higher quality. Attorney General Martha Coakley, the state's top insurers and several consumer groups argue that price is a critical issue.

28 Jul 2012

Long-term linagliptin effective treatment for Type 2 diabetes

Linagliptin is an effective and well-tolerated therapy for the long-term management of Type 2 diabetes, say the authors of an open-label extension study published in the International Journal of Clinical Practice.

27 Jul 2012

Anticancer benefit to giving birth after 30

Women who last give birth after the age of 30 years have a decreased risk for endometrial cancer, researchers report in the American Journal of Epidemiology.

27 Jul 2012

TB combination drug: an interview with Mel Spigelman, MD, CEO and President of TB Alliance

TB is a leading global killer. It is the second leading infectious disease in the world, behind HIV. TB is spread through the air, so it can affect anyone, but has its worst impact on impoverished communities and those people with HIV.

27 Jul 2012

Roundup: Ore. Gov. suggests malpractice reform; Mass. Gov. proposes new scrutiny for health care providers; Texas has offered HPV vaccine since 2007

The state can cut health care costs and reduce the number of medical-related lawsuits by requiring earlier notification of injuries as well as pretrial mediation, according to a recommendation Gov. John Kitzhaber issued Wednesday. The product of closed-door talks between representatives of interest groups including the Oregon Medical Association and the Oregon Trial Lawyers Association, Kitzhaber's recommendation now goes to a work group including lawmakers, a trial lawyer and doctor that begins public meetings next week.

27 Jul 2012

Navidea announces results from Lymphoseek Phase 3 trial on head and neck squamous cell carcinoma

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, noted today that individual site, investigator-initiated results of an ongoing Phase 3 clinical trial of 99m-Tc-Tilmanocept (Lymphoseek) were presented at the American Head and Neck Society's 8th International Conference on Head and Neck Cancer (ICHNC), held in Toronto, July 21-25, 2012.

27 Jul 2012

Takeda, Sucampo file AMITIZA sNDA with FDA for treatment of opioid-induced constipation

Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A. Inc. today announced the filing of a supplemental new drug application (sNDA) with the US Food and Drug Administration (FDA) seeking approval for a new indication for AMITIZA (lubiprostone) for the treatment of opioid-induced constipation (OIC) in patients with chronic, non-cancer pain.

26 Jul 2012

Gilead Sciences second quarter total revenues increase 13% to $2.41 billion

Gilead Sciences, Inc. announced today its results of operations for the quarter ended June 30, 2012.

26 Jul 2012

Oral News and Research

Screening tool could help oral cancer detection

Opinion of artificial hydration varies by ethnicity

Research supports ability of some herbal agents against sunburn

Teplizumab type I diabetes prevention study now enrolls younger children

Array BioPharma announces positive results from ARRY-797 Phase 2 trial on osteoarthritis

Top-line results from Pfizer's tofacitinib Phase 3 study on moderate-to-severe active RA

Flap design affects recovery from wisdom tooth surgery

Treatments for peripheral neuropathic pain compared

Stem cell therapy holds promise for craniofacial bone repair

Sleep related diabetes risk needs attention

Encouraging results from Tonix TNX-102 SL clinical trial for fibromyalgia syndrome

Patients with plantar fasciitis experience less pain and improved QOL after standard radiation therapy

Roundup: Mass. lawmakers struggle to reach agreement on cost controls; $100M grant for Calif. stem cell research; N.C. to move mentally ill from elderly homes

Long-term linagliptin effective treatment for Type 2 diabetes

Anticancer benefit to giving birth after 30

TB combination drug: an interview with Mel Spigelman, MD, CEO and President of TB Alliance

Roundup: Ore. Gov. suggests malpractice reform; Mass. Gov. proposes new scrutiny for health care providers; Texas has offered HPV vaccine since 2007

Navidea announces results from Lymphoseek Phase 3 trial on head and neck squamous cell carcinoma

Takeda, Sucampo file AMITIZA sNDA with FDA for treatment of opioid-induced constipation

Gilead Sciences second quarter total revenues increase 13% to $2.41 billion

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News